Arix Bioscience Share Discussion Threads

[ohisay] 21/2/2021 01:50

https://www.thetimes.co.uk/article/neil-woodfords-no-monkey-says-new-partner-clifford-press-ww8nvk88t Pretty clear from this that Acacia isnt going to make the same mistake it did with Synairgen and sell out of Arix anytime soon .. What started as a request for advice has grown into a partnership. Woodford’s return, revealed in a tearful interview last weekend, is linked to an advisory role on the biotech portfolio now owned by Acacia Research, the Nasdaq-listed company that Press runs. The news of a comeback came with a comment from Press calling Woodford a “truly exceptional investment manager”. The announcement was met with disbelief from retail investors who lost a minimum of 35 per cent of their money in the failure of Woodford’s fund management empire, and surprise from regulators. Press is convinced there is still a role for Woodford. He said the stockpicker’s demise had left a “void” in the UK for life sciences investment. “It would be a great tragedy if it was destroyed and not rebuilt,” he added. “We’ve had to operate with Woodford in the background, and we didn’t like doing that. We decided to come out and make it clear that he has been very helpful to us.”

[ohisay] 16/2/2021 14:50

https://www.telegraph.co.uk/investing/funds/woodford-investors-185m-loss-power-former-managers-new-venture/

[chesil356] 15/2/2021 12:22

Looks like the seller has now cleared here imo

[pinemartin9] 12/2/2021 12:27

LONDON, 11 February 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, will announce its annual results for the year ended 31 December 2020, on Tuesday 9th March 2021. Arix will host a virtual analyst presentation on the same day, at 12:00pm GMT, followed by a Q&A session, accessible via conference call or webcast. The webcast of the presentation will be available on the Company's investor relations website at hxxps://arixbioscience.com/investor-relations/events-presentations.

[arthur_lame_stocks] 09/2/2021 15:11

Sorry I can't help you there.

[snappler] 09/2/2021 14:45

I hold Arix as well and looking for research about the other Neil Woodford backed biotech Investment Company, Malin Corp. The share price is EUR 6. i calculated the fair value around EUR 9, taking the recent share price performance of Immunocore and the sale of kymab into account. Do you know any interesting sites about malin?

[arthur_lame_stocks] 09/2/2021 13:33

I bought a few of these today after ST's write up. With all that cash the investments are in the price at a significant discount to book value. I like a bit of blue sky investing and hopefully one or more of the other investments will have a successful outcome.

[n0rbie] 05/2/2021 08:47

Good call!

[ohisay] 05/2/2021 08:32

ST today ... I estimate the company now holds net cash of about £155m (114p a share), ..I have stated the cash position after allowing for a £18.8m tax liability on the VelosBio disposal based on a 15 per cent tax charge.

[yellowdog] 04/2/2021 18:39

And I was right. ST gives it a great write up and we should see a good rise tomorrow. However I do see it as a long term investment that will do very well.

[chesil356] 04/2/2021 18:11

It's at the bottom of a rising trend at the moment if you believe charts, the top of the trend is 267p would be nice to hit that, I think it will take news and whoever is drip feeding shares to finish.

[yellowdog] 04/2/2021 11:03

There's a good chance it will be in Simon Thompson's Bargain Shares in the I.C tomorrow. He tipped in December at 176p and it's now 172p so even more of a bargain. If so it will bounce from here.

[ohisay] 26/1/2021 16:14

But estimated cash here around 128p per share ..And Hardmans current Nav estimate is 274p a share . So market is effectively discounting the funds holdings by an enormous amount . viz .175p current share price less cash of 128p is 47p market valuation for remaining assets. Portfolio apparent Nav is 274p less 128p cash.....146p . Discount of 68%..

[ohisay] 26/1/2021 14:23

Seems like there might be a seller around ..Acacia (19% shareholder) probably - based on recent behaviour in SNG where they sold out much too early.

[chesil356] 22/1/2021 16:13

I suspect he's not to bothered, he knows the value of the investments Arix have and they are well above what he paid.

[piano man] 19/1/2021 18:06

Does anyone know the management fees please?

[supernumerary] 07/1/2021 20:45

So now it's a question of timing ;)

[n0rbie] 07/1/2021 10:43

Currently able to buy cheaper than the Chairman did!

[chesil356] 07/1/2021 10:17

Looks like we both might get a chance to top up! Looks like a bit of momentum driven selling by pi's. Share price testing £2 resistance. If anything fundamentals have improved since my last purchase. Final results early March where nav will be far greater than £2 so this is definitely a buying opportunity for me.

[supernumerary] 31/12/2020 12:52

I was hoping for a bit of weakness myself, but have now abandoned that hope, so will have to be satisfied with what I have. Another year like this one would be good :) HNY all!

[chesil356] 31/12/2020 09:23

Yes agreed, the directors buy was great to see.I've got a long term plan for my Arix holding of a minimum of 5 years. I'm adding on weakness when I can and have no plan to sell any. I can only see the NAV increasing from here.

[supernumerary] 30/12/2020 10:04

Nice quiet board :) I was surprised there was no comment on the director buy - quite a strong statement of intent I thought.

[ohisay] 12/12/2020 23:32

https://www.ft.com/content/60cf5a00-a988-464a-8772-6a3bfed358c7

[ohisay] 12/12/2020 03:11

https://www.voxmarkets.co.uk/articles/arix-bioscience-alba-mineral-resources-and-vadim-alexander-on-polarean-imaging-db30972/ From last week.... 2'/30 in